TERUMO BCT SPECTRA OPTIA APHERESIS SYSTEM
Contract Opportunity Analysis
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a fixed-price sole source purchase order for the Terumo BCT Spectra Optia Apheresis System. This procurement aims to acquire critical equipment for blood cell collection, therapeutic apheresis, and cell processing, which is essential for maintaining high standards of patient care at the NIH Clinical Center's Department of Transfusion Medicine. The Spectra Optia Apheresis System is recognized for its advanced capabilities, including continuous-flow centrifugation and optical detection technology, which enhance operational efficiency and patient care. Interested parties capable of providing similar products must submit a capability statement by May 5, 2025, at 12:00 PM EST to Emeka Onyejekwe at emeka.onyejekwe@nih.gov for consideration.